Tamtuvetmab, CAS 1608122-71-9

Description: Tamtuvetmab (AT-005), a caninised version of blontuvetmab targeting CD52, enhances progression-free survival (PFS) and demonstrates in vivo efficacy for treating naïve T-cell lymphoma (LSA) in dogs. The compound has received veterinary approval [1] [2].

CAS Number: 1608122-71-9

• Artikelnummer: TGMT81046-5mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T81046-5mg
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK